Additionally, dysregulated crosstalk between AKT, Nrf2, and NFκB signaling engages a fundamental role in the development and progression of metabolic syndrome by augmenting oxidative stress and inflammation (Salminen et al., 2011; Liu et al., 2016; Kracht et al., 2020). This evidence concerns the gene NFE2L2 and metabolic syndrome.